Compare CMPX & NECB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CMPX | NECB |
|---|---|---|
| Founded | 2014 | 1934 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 371.0M | 337.9M |
| IPO Year | 2020 | 2021 |
| Metric | CMPX | NECB |
|---|---|---|
| Price | $2.09 | $25.74 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 1 |
| Target Price | $14.57 | ★ $30.00 |
| AVG Volume (30 Days) | ★ 3.8M | 30.4K |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 4.12% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.74 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $4.85 |
| Revenue Next Year | $934.41 | $8.45 |
| P/E Ratio | ★ N/A | $34.69 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.61 | $19.27 |
| 52 Week High | $6.88 | $26.14 |
| Indicator | CMPX | NECB |
|---|---|---|
| Relative Strength Index (RSI) | 40.68 | 61.24 |
| Support Level | $1.88 | $22.34 |
| Resistance Level | $2.47 | N/A |
| Average True Range (ATR) | 0.11 | 0.58 |
| MACD | 0.06 | 0.09 |
| Stochastic Oscillator | 31.82 | 81.86 |
Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.
NorthEast Community Bancorp Inc operates as a community-oriented financial institution. It is principally engaged in the business of attracting deposits and investing those funds into mortgage and commercial loans. It conducts activities throughout the Northeastern United States, including New York, Massachusetts, New Jersey, and Connecticut. The company offers a comprehensive line of banking products and services, including mobile banking as well as commercial real estate loans, commercial construction financing, lines of credit, and term loans. It also offers investment advisory and financial planning services.